Risk factors for rheumatoid arthritis-related lung diseases include later RA onset, longer RA duration, and previous pulmonary infections.

RA may originate in part due to airway inflammation, and ongoing research seeks to determine the precise role of the lungs in the pathogenesis of RA. Patients with RA are at increased risk for ...

Patients with rheumatoid arthritis (RA) and RA-interstitial lung disease are at an increased risk of lung cancer, according to the results of a retrospective, matched cohort study. "Prior studies have ...

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients with rheumatoid arthritis more effectively than either approach alone.

Combining genetic features with clinical data improved the performance of a pulmonary fibrosis prediction score for people with rheumatoid arthritis. A new combined risk score that incorporates ...

Can rheumatoid arthritis affect your lungs? Answer From April Chang-Miller, M.D. Although rheumatoid arthritis primarily affects joints, it sometimes also causes lung disease. Occasionally, lung ...

For the first time, researchers have shown that a class of anti-fibrotic drugs slows the progression of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Research conducted, ...

New findings reveal that rheumatoid arthritis (RA) disease activity significantly affects the severity of interstitial lung disease (ILD), both radiologically and physiologically, in patients with RA ...

PHILADELPHIA (WPVI) -- Having a severe lung disease can be debilitating and that loss of control can wreak havoc on your mental health. 62-year-old Michael Parsley enjoys his daily walks with his dog.

Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis who receive immune checkpoint inhibition for metastatic lung cancer have ...

(RTTNews) - Shares of AnaptysBio Inc. (ANAB) are down over 50% from their 52-week high of $41.31, recorded last August, with the stock now hovering around the $20 level. This clinical-stage ...